These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32428837)

  • 1. The Novel Phospholipid Mimetic KPC34 Is Highly Active Against Acute Myeloid Leukemia with Activated Protein Kinase C.
    Alexander PM; Kucera GL; Pladna KM; Pardee TS
    Transl Oncol; 2020 Jul; 13(7):100780. PubMed ID: 32428837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia.
    Alexander PM; Caudell DL; Kucera GL; Pladna KM; Pardee TS
    PLoS One; 2017; 12(6):e0179798. PubMed ID: 28644853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
    Yamauchi T; Negoro E; Kishi S; Takagi K; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
    Biochem Pharmacol; 2009 Jun; 77(12):1780-6. PubMed ID: 19428333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells.
    Song JH; Kim SH; Kweon SH; Lee TH; Kim HJ; Kim HJ; Kim TS
    Int J Oncol; 2009 Apr; 34(4):1165-71. PubMed ID: 19287976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression Levels of Human Equilibrative Nucleoside Transporter 1 and Deoxycytidine Kinase Enzyme as Prognostic Factors in Patients with Acute Myeloid Leukemia Treated with Cytarabine.
    Candelaria M; Corrales-Alfaro C; Gutiérrez-Hernández O; Díaz-Chavez J; Labardini-Méndez J; Vidal-Millán S; Herrera LA
    Chemotherapy; 2016; 61(6):313-8. PubMed ID: 27119162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ubiquitin ligase Herc1 modulates the response to nucleoside analogs in acute myeloid leukemia.
    Jankovic M; Poon WW; Gonzales-Losada C; Vazquez GG; Sharif-Askari B; Ding Y; Craplet-Desombre C; Ilie A; Shi J; Wang Y; Jayavelu AK; Orthwein A; Mercier FE
    Blood Adv; 2024 Aug; ():. PubMed ID: 39093953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells.
    Sarkar M; Han T; Damaraju V; Carpenter P; Cass CE; Agarwal RP
    Biochem Pharmacol; 2005 Aug; 70(3):426-32. PubMed ID: 15950950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FLT3-ITD induces ara-C resistance in myeloid leukemic cells through the repression of the ENT1 expression.
    Jin G; Matsushita H; Asai S; Tsukamoto H; Ono R; Nosaka T; Yahata T; Takahashi S; Miyachi H
    Biochem Biophys Res Commun; 2009 Dec; 390(3):1001-6. PubMed ID: 19853583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
    Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
    Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia.
    Veuger MJ; Honders MW; Willemze R; Barge RM
    Eur J Haematol; 2002 Sep; 69(3):171-8. PubMed ID: 12406011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
    Xie XT; Jiang SY; Li BS; Yang LL
    Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):276-80. PubMed ID: 19099730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome.
    Macanas-Pirard P; Broekhuizen R; González A; Oyanadel C; Ernst D; García P; Montecinos VP; Court F; Ocqueteau M; Ramirez P; Nervi B
    Oncotarget; 2017 Apr; 8(14):23073-23086. PubMed ID: 28160570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.
    Galmarini CM; Thomas X; Calvo F; Rousselot P; Rabilloud M; El Jaffari A; Cros E; Dumontet C
    Br J Haematol; 2002 Jun; 117(4):860-8. PubMed ID: 12060121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octadecyloxyethyl Adefovir Exhibits Potent in vitro and in vivo Cytotoxic Activity and Has Synergistic Effects with Ara-C in Acute Myeloid Leukemia.
    Khoury H; He R; Schimmer A; Beadle JR; Hostetler KY; Minden MD
    Chemotherapy; 2018; 63(4):225-237. PubMed ID: 30372692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.
    Degwert N; Latuske E; Vohwinkel G; Stamm H; Klokow M; Bokemeyer C; Fiedler W; Wellbrock J
    Eur J Haematol; 2016 Sep; 97(3):239-44. PubMed ID: 26613208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High glucose suppresses expression of equilibrative nucleoside transporter 1 (ENT1) in rat cardiac fibroblasts through a mechanism dependent on PKC-zeta and MAP kinases.
    Grden M; Podgorska M; Kocbuch K; Rzepko R; Szutowicz A; Pawelczyk T
    J Cell Physiol; 2008 Apr; 215(1):151-60. PubMed ID: 17941087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-expression profiling reveals down-regulation of equilibrative nucleoside transporter 1 (ENT1) in Ara-C-resistant CCRF-CEM-derived cells.
    Takagaki K; Katsuma S; Kaminishi Y; Horio T; Nakagawa S; Tanaka T; Ohgi T; Yano J
    J Biochem; 2004 Nov; 136(5):733-40. PubMed ID: 15632314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytarabine-resistant leukemia cells are moderately sensitive to clofarabine in vitro.
    Yamauchi T; Uzui K; Nishi R; Shigemi H; Ueda T
    Anticancer Res; 2014 Apr; 34(4):1657-62. PubMed ID: 24692694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs Mediated Regulation of Expression of Nucleoside Analog Pathway Genes in Acute Myeloid Leukemia.
    Bhise NS; Elsayed AH; Cao X; Pounds S; Lamba JK
    Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 31022985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) gene.
    Stegmann AP; Honders MW; Hagemeijer A; Hoebee B; Willemze R; Landegent JE
    Ann Hematol; 1995 Jul; 71(1):41-7. PubMed ID: 7543292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.